빔 테라퓨틱스(주)
US ˙ NasdaqGS ˙ US07373V1052

SecurityBEAM / Beam Therapeutics Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership826,061 shares
Latest Disclosed Value $ 19,685,034
UBS Group AG ownership in BEAM / Beam Therapeutics Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 826,061 shares of Beam Therapeutics Inc. (US:BEAM) valued at $19,685,034 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 973,843 shares of Beam Therapeutics Inc.. This represents a change in shares of -15.18% during the quarter. The current value of the position is $27,127,843 USD.

UBS Group AG has a history of taking positions in derivatives of the underlying security (BEAM) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

BEAM / Beam Therapeutics Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F BEAM THERAPEUTICS COM 07373V105 826,061 -147,782 -15.18 19,685 -27.08 0.0006
2026-01-29 2025-12-31 13F BEAM THERAPEUTICS COM 07373V105 973,843 -163,790 -14.40 26,995 -2.23 0.0044
2025-11-13 2025-09-30 13F BEAM THERAPEUTICS COM 07373V105 1,137,633 -26,261 -2.26 27,610 39.47 0.0043
2025-08-14 2025-06-30 13F BEAM THERAPEUTICS COM 07373V105 1,163,894 -297,895 -20.38 19,798 -30.65 0.0034
2025-05-13 2025-03-31 13F BEAM THERAPEUTICS COM 07373V105 1,461,789 -357,847 -19.67 28,549 -36.74 0.0052
2025-02-14 2024-12-31 13F BEAM THERAPEUTICS COM 07373V105 1,819,636 1,630,442 861.78 45,127 873.59 0.0083
2024-11-14 2024-09-30 13F BEAM THERAPEUTICS COM 07373V105 189,194 26,617 16.37 4,635 21.69 0.0010
2024-08-14 2024-06-30 13F BEAM THERAPEUTICS COM 07373V105 162,577 -87,664 -35.03 3,809 -53.93 0.0009
2024-05-13 2024-03-31 13F BEAM THERAPEUTICS COM 07373V105 250,241 -10,259 -3.94 8,268 16.60 0.0021
2024-02-09 2023-12-31 13F BEAM THERAPEUTICS COM 07373V105 260,500 141,102 118.18 7,091 146.95 0.0021
2023-11-09 2023-09-30 13F BEAM THERAPEUTICS COM 07373V105 119,398 -7,808 -6.14 2,872 -29.30 0.0010
2023-08-11 2023-06-30 13F BEAM THERAPEUTICS COM 07373V105 127,206 73,921 138.73 4,062 148.99 0.0014
2023-05-12 2023-03-31 13F BEAM THERAPEUTICS COM 07373V105 53,285 -85,420 -61.58 1,632 -69.93 0.0006
2023-02-08 2022-12-31 13F BEAM THERAPEUTICS COM 07373V105 138,705 130,546 1,600.02 5,425 1,294.34 0.0020
2022-11-10 2022-09-30 13F BEAM THERAPEUTICS COM 07373V105 8,159 -31,393 -79.37 389 -74.59 0.0002
2022-08-10 2022-06-30 13F BEAM THERAPEUTICS COM 07373V105 39,552 -26,206 -39.85 1,531 -59.37 0.0006
2022-05-16 2022-03-31 13F BEAM THERAPEUTICS COM 07373V105 65,758 27,174 70.43 3,768 22.54 0.0013
2022-02-14 2021-12-31 13F BEAM THERAPEUTICS COM 07373V105 38,584 -10,167 -20.85 3,075 -27.49 0.0009
2021-11-15 2021-09-30 13F BEAM THERAPEUTICS COM 07373V105 48,751 19,781 68.28 4,241 13.73 0.0013
2021-08-13 2021-06-30 13F BEAM THERAPEUTICS COM 07373V105 28,970 -9,559 -24.81 3,729 20.91 0.0012
2021-05-12 2021-03-31 13F BEAM THERAPEUTICS COM 07373V105 38,529 16,773 77.10 3,084 73.65 0.0010
2021-02-11 2020-12-31 13F BEAM THERAPEUTICS COM 07373V105 21,756 17,295 387.69 1,776 1,514.55 0.0006
2020-11-12 2020-09-30 13F BEAM THERAPEUTICS COM 07373V105 4,461 -2,774 -38.34 110 -45.81 0.0000
2020-07-31 2020-06-30 13F BEAM THERAPEUTICS COM 07373V105 7,235 6,435 804.38 203 1,350.00 0.0001
2020-05-01 2020-03-31 13F BEAM THERAPEUTICS COM 07373V105 800 800 14 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-08-13 2021-06-30 13F BEAM THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-12 2021-03-31 13F BEAM THERAPEUTICS COM Call 49,600 3,970 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.